The characteristics of sequential human immunodeficiency virus type 1 (HIV-1) isolates from 12 seroconverters among injection drug users selected for either rapid or slow disease progression were evaluated. All 6 patients who developed AIDS within 5 years were initially infected with syncytiuminducing (SI) variants or showed a transition from non-SI -inducing (NSI) to SI variants. Detection of SI variants was associated with rapid decline of both CD8
Epidemiologic studies have shown that the median time from between the degree of CD8 / T lymphocyte anti-HIV suphuman immunodeficiency virus type 1 (HIV-1) infection to the pressive activity and clinical status has also been reported [34] . development of AIDS is 8 -12 years [1 -5] , with Ç20% of Recovery of replication-competent HIV-1 from some long-term infected people developing AIDS within 5 years and another nonprogressors suggests that host factors are responsible for 5% showing minimal disease progression after §10 years [6 - the control of HIV-1 replication in vivo [30, 35] . People who 10]. The factors that influence this variable rate of disease are homozygous for a deletion in the CCR-5 gene are relatively progression are poorly understood. It is clear that HIV-1 repliresistant to HIV-1 infection [36 -38] , and heterozygosity for cation is active during all stages of the disease, as monitored this deletion may also provide some degree of protection in both the peripheral blood [11 -15] and lymphoid tissues in against disease progression [36, 37, 39] . vivo [16 -17] .
HIV-1 isolates have been grouped phenotypically into two Phenotypic properties of the various HIV-1 variants, such as classes: the macrophage-tropic (M-tropic), non-SI -inducing replication rate, cell tropism, and syncytium-inducing (SI) ability, (NSI) class and the T cell line -tropic (T-tropic), SI class (for correlate with the stage and rate of disease progression [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] .
a recent review see [40] ). M-tropic, NSI viruses use primarily The occurrence of a cluster of slowly progressing patients who CCR-5 as the coreceptor for entry [41 -45] , while the T-tropic, had been exposed to one source of attenuated HIV-1 demon-SI viruses use CXCR-4 [46] . The M-tropic, NSI viruses prestrated that the phenotype of the infecting virus can determine dominate during HIV-1 transmission and can be detected at all subsequent disease progression [29] . Infection with apparently stages of HIV-1 infection [40] . In contrast, the T-tropic, SI attenuated HIV-1 variants may have also contributed to the slow viruses are more often isolated from persons with late-stage disease progression in other patients [30, 31] .
disease [40] . An association of SI viruses with rapid disease Disease progression may also be affected by host factors.
progression has been demonstrated, but a causal relationship For example, the appearance of virus-specific CD8 / cytotoxic has not been established [40] . T lymphocyte activity has been associated with control of vire-AIDS among injection drug users (IDUs) remains a major mia during primary HIV-1 infection [32, 33] , and a correlation and growing public health problem. IDUs account for more than one-third of the total AIDS cases in the United States and represent one of the fastest growing areas of the HIV-1 epi- We limited subject selection to those participants with an interval of õ9 months between the last seronegative and the first sero-NOTE. All subjects were African American, and all subjects except R2 positive visits. The mid-point between these visits was taken as used injection drugs during seroconversion interval. Clinical AIDS was defined by 1993 CDC criteria [77] . CMV, cytomegalovirus infection; PCP, Pneumothe estimated time of infection. Of the ALIVE subjects, 135 were cystis carinii pneumonia; MAI, Mycobacterium avium-intracellulare complex; considered eligible, and we further required that they have at least Pneu, recurrent pneumonia.
three sequential visits on which T cell counts were done. We identified 105 qualified seroconverters, of whom 6 had developed clinical AIDS within 5 years (rapid progressors). To have a total of 12 subjects, we also identified randomly 6 control subjects who served PBMC (1 1 10 6 ) were washed once with RPMI 1640 and were eligible on the basis of the following criteria: They had more resuspended in 250 mL of lysis buffer (10 mM Tris hydrochloride than three sequential T cell counts, they had no signs or symptoms [pH 8 .3], 50 mM KCl, 2.5 mM MgCl2, 1% NP-40, 1% Tween 20, of clinical AIDS for at least 5 years, and they had initial CD4 / T 100 mg of proteinase K/mL). Samples were then incubated at 65ЊC cell counts similar to those of the rapid progressors. for 2 h, followed by heating at 95ЊC for 10 min. Cell lysates Protease inhibitor or combination therapy was not used by these corresponding to 2 1 10 5 PBMC were subjected to PCR, using subjects. Although zidovudine was used by some individuals at external env primers as previously described [49] . The first PCR certain time points, no subject received zidovudine for the first (10 mL) was subjected to a second PCR using nested primers year after seroconversion. Also, the rapid progressors tended to containing BamHI or EcoRI restriction enzyme site as previously receive zidovudine earlier than slow progressors because zidovuddescribed [49] . Both first-and second-round PCRs were run at ine was given to individuals who had low CD4 cell counts.
95ЊC for 2 min, followed by 30 cycles of denaturing for 30 s at Virus isolation and characterization. Viable peripheral blood 95ЊC, annealing for 30 s at 60ЊC, and synthesis for 45 s at 72ЊC. mononuclear cells (PBMC) (2 1 10 6 ) from cryopreserved PBMC At the end of the 30 cycles, the samples were held at 72ЊC for 10 were cocultured with 2 1 10 6 phytohemagglutinin-stimulated min and then stored at 4ЊC for further analysis. The nested PCR PBMC from HIV-seronegative donors for virus isolation as preproducts were digested with BamHI and EcoRI and cloned into viously described [48] . Culture media were monitored for p24 pGEM7Z(/). Recombinant plasmids that contained PCR products antigen (DuPont NEN, Wilmington, DE) twice a week for up to were sequenced by the Sanger method using T7 and SP6 primers 4 weeks after coculture. A positive culture was defined by two from both directions. HIV-1 env sequences were also determined consecutive HIV-1 p24 antigen values ú200 pg/mL. Ninety-five from infected MT-2 cells and macrophages as described above. percent of HIV-1-infected patients, who were not on effective antiviral therapy or were not long-term nonprogressors with stable, high CD4 cell counts, were culture positive using this procedure.
Results
The ability of HIV-1 isolates to replicate in MT-2 cells [49] or primary macrophages [50] was evaluated as previously described.
Relationship between characteristics of sequential primary
Cell-free viruses recovered from infected PBMC were passed twice HIV-1 isolates from IDUs and disease progression. Demo- estimated time of infection (figure 1). Three others (SW1 -period of time. One control subject (S1) had a significant decline in CD4 / T cells but also had a compensatory increase in SW3) also developed AIDS within 4 years of the estimated infection date (figure 1); however, they had stable CD4 cell CD8 / T cells (figure 1). To investigate the possible relationship between disease procounts for the first 20 -40 months after infection before having a rapid decline in CD4
/ T cells and progressing to AIDS. gression and the characteristics of HIV-1 variants, sequential primary HIV-1 isolates were obtained from all subjects except 1 Another feature of the 6 rapidly progressing subjects was that they had no compensatory increase in CD8 / T cell counts slow progressor (S6), who maintained stable and very high CD4 cell counts (figure 1); the primary virus isolate from the first during the period of rapid CD4 / T cell decline. Consequently, all 6 had a rapid total T cell (CD3 / ) decline prior to progressing seropositive visit was the only isolate obtained from this subject. All primary HIV-1 isolates were replication competent in phytoheto AIDS ( figure 1) .
In contrast to the subjects with rapid disease progression, 6 magglutinin-stimulated PBMC from HIV-negative donors. The peak production of HIV-1 p24 antigen in the culture supernatants control subjects (S1 -S6) were asymptomatic and maintained relatively stable total T cell counts ( figure 1) shown). The viral phenotype (NSI or SI) was determined using NSI variants were consistently detected in the 5 control subjects (S1-S5) who maintained relatively stable total T cell counts and MT-2 cells as previously described [49] . The NSI phenotype was characterized by a p24 level of õ5 pg/mL in the supernatant from did not progress to AIDS (figure 1). For subject S6, the viral phenotype was only available for the first seropositive visit (figure infected MT-2 cells and no observed syncytium formation during the first 3 weeks after infection. The SI phenotype was character-1). We obtained sequential viral env V3 sequences from uncultured PBMC samples that were obtained from subject S6 during ized by prominent syncytium formation in MT-2 cells, accompanied by p24 levels of ú100 ng/mL. subsequent visits (up to 5 years after infection). All of these sequences predicted the NSI phenotype (data not shown). SI isolates were detected in the 3 rapid progressors (R1 -R3) at the first seropositive visit and at subsequent visits (figure Genotypic analysis of HIV-1 env sequences using the first seropositive PBMC samples from subjects R1 -R3 confirmed 1). The remaining 9 subjects had NSI variants at this visit (figure 1). A transition from NSI to SI was detected in all 3 the presence of SI variants. It has been previously reported that M-tropic, NSI variants are the predominant viruses in the period subjects (SW1 -SW3) who progressed from stable CD4 / T cell counts to rapid declines in CD4 / T cell levels and development immediately following sexual [52, 53] or parenteral [54] transmission of HIV-1. Therefore, the detection of SI variants in 3 of AIDS (figure 1). For subjects SW1 and SW2, SI variants were first detected before the period of rapid CD4 / T cell and early seroconverters (R1 -R3) raised the possibility that these subjects had been coinfected with both NSI and SI variants total T cell decline ( figure 1) . A more precise time at which the NSI-to-SI transition occurred in subject SW3 could not be and that the SI variants may have constituted only a minor population in these subjects. determined.
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To address this question, HIV-1 env V3 loop sequences were determined from uncultured PBMC samples collected from these subjects at their first seropositive visits. Ten to 16 sequences were determined for each subject as previously described [49] . For subjects R2 and R3, homogenous viral sequences were obtained (figure 2), consistent with the interpretation that they were infected with a relatively restricted viral variant. At the same time, viral sequences from infected MT-2 cells were also analyzed to confirm the SI genotype. Viral sequences obtained from infected MT-2 cells representing SI sequences were also homogenous. The viral V3 loop sequences from uncultured PBMC samples of subjects R2 and R3 were identical to the sequences obtained from MT-2 cells infected with these isolates (figure 2). Previous studies have suggested that proviral sequences in PBMC samples obtained within 6 months after infection represent the virus strains that established the initial infection [52, 53] . Therefore, it is likely that the SI variants were the major viruses that established infection in subjects R2 and R3. However, the possibility that NSI variants established infection in subject R2 and R3 and rapidly underwent transition from NSI to SI strains cannot be excluded.
On the basis of V3 sequences, 2 major virus populations were detected in subject R1 (figure 2). The viral sequences, clone numbers 5 -9, from the uncultured PBMC samples matched the viral sequences from infected MT-2 cells and therefore represent SI variants. The existence of viral sequences in the uncultured PBMC samples that were not detected in the infected MT-2 cells suggests that NSI variants were also present in this subject at the time of sampling. These putative NSI variants have the genotype of NSI HIV-1 in the V3 loop. Although it is unusual to find very heterogeneous HIV-1 sequences in recent seroconverters, it is also unlikely that this was due to PCR contamination for several reasons. First, sequences identified from R1 were not found in the samples from the other 11 seroconverters and are distinct from sequences of HIV-1 clones used in the laboratory (data not shown). Second, phylogenetic analysis of env sequences from all 12 subjects indicated that the sequences from R1 clustered together but not with sequences from other unrelated subjects (data not shown). Third, samples from subsequent visits of R1 were also ana- NOTE. Replication of HIV-1 in MT-2 cells and primary macrophages was monitored by measuring p24 (ng/mL) in supernatants of infected cells. T-tropic, T cell line -tropic; M-tropic, macrophage-tropic.
* Indicates õ6.25 pg/mL. required for initial infection during HIV-1 transmission [40, was not due to the coexistence of different variants. Therefore, the SI variants from subjects R1 -R3 were dual tropic. 53]. Thus a possible explanation for the presence of SI variants at the first seropositive visits for R1 -R3 was that they can infect macrophages efficiently. Dual-tropic HIV-1 strains that Discussion can replicate in established T cell lines as well as primary macrophages have been described [57 -59] .
In this study, the relationship between the characteristics of To test whether these isolates were dual tropic, we tested primary HIV-1 isolates and a combination of rapid total T cell primary isolates from subjects R1 -R3 for their ability to replidecline (CD4 / and CD8 / T cells) and development of AIDS cate in MT-2 cells and primary macrophages, as previously were systematically evaluated in 12 documented seroconvertdescribed [49 -50] . To exclude the possibility that the efficient ing IDUs. Previous studies of this type in IDUs are scarce. replication of these 3 primary isolates in macrophages could Several interesting patterns of disease progression were noted. be attributed to the presence of NSI variants, these virus isolates First, SI variants were detected in all of the 6 subjects who were passed twice through MT-2 cells, which would select for had the most rapid disease progression. This high incidence of viruses using the CXCR4 coreceptor (i.e., SI variants), and SI variants in patients who developed AIDS is in contrast to were then analyzed for replication in MT-2 cells and primary the lower prevalence of SI variants among IDUs who developed macrophages. The dual-tropic molecular clone 89.6 [57] was AIDS in the Amsterdam cohort [61] . Second, the SI variants used as a control. All 3 SI isolates from the rapid progressors that were responsible for initial infection in 3 of the rapid replicated efficiently in both MT-2 cells and macrophages (taprogressors were apparently dual tropic. Third, detection of SI ble 2). The replication kinetics of these viruses in MT-2 cells variants was associated not only with rapid CD4 / T cell decline and macrophages were similar to those of the dual-tropic clone but also with rapid CD8 / T cell decline. 89.6. The M-tropic strain HIV-1 Ba-L [60] replicated efficiently It has been reported that SI variants can be detected in Ç50% in macrophages but not in MT-2 cells; the reverse was true for of AIDS patients [24, 28] . Although this is apparently the case the T-tropic strain HXB2 (table 2). Primary NSI isolates from for homosexual men in both the United States [24] and Europe the first seropositive visit of 3 slow disease progressors also [28] , the Amsterdam study reported a lower proportion (21%) replicated efficiently in macrophages (data not shown).
of SI variants in IDUs who developed AIDS [61] . This differTo further exclude the possibility that the efficient replication ence raises the possibility that the route of virus transmission of these 3 primary isolates in macrophages could be attributed or that illicit drug use itself might influence the selection of to the presence of NSI variants, viral env sequences were deter-HIV-1 variants. In this study, SI variants were detected in all mined from both infected MT-2 cells and macrophages ( figure  6 IDUs who developed AIDS within 5 years of seroconversion 3). Homogenous V3 loop sequences (5 clones) were identified from the Baltimore ALIVE cohort. It is possible that this high from each virus isolate infected -MT-2 cells for all 3 subjects. rate of SI variants results from the fact that we examined the More important, viral V3 loop sequences from the infected most rapid disease progressors, while in the Amsterdam study macrophages matched those from infected MT-2 cells in all the prevalence of SI was investigated for all patients who develcases. 
CD8
/ cells express high levels markers in resting PBMC, these cells usually cannot support productive HIV-1 infection without exogenous stimulation by of CXCR-4, the coreceptor used by SI variants [75] . A rapid decline in the total T cell count beginning Ç2 years before the mitogen and cytokines [62 -65] . On the other hand, tissue macrophages are more susceptible to HIV-1 replication [59, 66] . development of AIDS has been observed in several cohort studies, suggesting failure of T cell homeostasis [76, 77] . These At the time of HIV-1 transmission, more macrophages than activated CD4
/ T cells may be available for initial virus infecobservations suggest that the possible association between the emergence of particular strains of HIV-1, such as SI variants, tion, and therefore the M-tropic variants are favored. Detection in early seroconverters of primary SI variants that can also and a rapid decline in total T cell count deserve further investigation. efficiently replicate in macrophages is consistent with the interpretation that the ability to infect macrophages, rather than SI or NSI phenotype per se, may be critical for HIV-1 transmission.
